Divalproex sodium and Basal cell carcinoma - a phase IV clinical study of FDA data

Summary:

Basal cell carcinoma is reported as a side effect among people who take Divalproex sodium (divalproex sodium), especially for people who are male, 60+ old, also take Zometa, and have Prostate cancer.

The phase IV clinical study analyzes which people have Basal cell carcinoma when taking Divalproex sodium. It is created by eHealthMe based on reports of 9,295 people who have side effects when taking Divalproex sodium from the FDA, and is updated regularly.

What is Divalproex sodium?

Divalproex sodium has active ingredients of divalproex sodium. It is often used in epilepsy. eHealthMe is studying from 9,483 Divalproex sodium users. Check the latest studies of Divalproex sodium.

What is Basal cell carcinoma?

Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills) is found to be associated with 1,092 drugs and 1,381 conditions by eHealthMe. Check the latest studies of Basal cell carcinoma.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

9,295 people reported to have side effects when taking Divalproex sodium.
Among them, 15 people (0.16%) have Basal cell carcinoma.

Could Divalproex sodium cause Basal cell carcinoma?

Among these 15 people:

What is the gender of people who have Basal cell carcinoma when taking Divalproex sodium? *

female: 20 %
male: 80 %

What is the age of people who have Basal cell carcinoma when taking Divalproex sodium? *

What are other drugs people take besides Divalproex sodium? *

What are other side effects people have besides Basal cell carcinoma? *

Weight Decreased: 13 people, 86.67%
Haemorrhage (bleeding): 11 people, 73.33%
Aortic Calcification (aortic calcification sign of heart valve disease): 11 people, 73.33%
Rotator Cuff Syndrome (a spectrum of conditions affecting the rotator cuff tendons of the shoulder): 11 people, 73.33%
Osteomyelitis (infection of bone): 11 people, 73.33%
Blood Glucose Increased: 11 people, 73.33%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 11 people, 73.33%
Clavicle Fracture: 11 people, 73.33%
Enlarged Heart: 11 people, 73.33%
Anaemia (lack of blood): 11 people, 73.33%

What are the existing conditions these people have? *

Prostate Cancer: 10 people, 66.67%
Psoriasis (immune-mediated disease that affects the skin): 4 people, 26.67%
High Blood Cholesterol: 3 people, 20.00%
Thyroid Diseases: 2 people, 13.33%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 2 people, 13.33%
Automatic Bladder (nerve impulses between the bladder and the spinal cord remain intact and the bladder can be trained to empty by reflex (spastic) action): 2 people, 13.33%
Depression: 2 people, 13.33%
Diabetes: 2 people, 13.33%
Gastric Disorder (disease of stomach): 2 people, 13.33%
Gastritis (inflammation of stomach): 2 people, 13.33%

* Approximation only. Some reports may have incomplete information.

Do you take Divalproex sodium and have Basal cell carcinoma?

- Check whether Basal cell carcinoma is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Divalproex sodium:

Divalproex sodium (9,483 reports)

Browse all side effects of Divalproex sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Basal cell carcinoma:

Basal cell carcinoma (1,092 drugs)

Browse all the conditions that are associated with Basal cell carcinoma:

Basal cell carcinoma (1,381 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on divalproex sodium (the active ingredients of Divalproex sodium) and Divalproex sodium (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.